# Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

> **NCT04101370** · PHASE1 · COMPLETED · sponsor: **Geropharm** · enrollment: 64 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Bosentan 125 mg
- **DRUG:** Tracleer 125Mg Tablet

## Key facts

- **NCT ID:** NCT04101370
- **Lead sponsor:** Geropharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-24
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-20
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04101370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04101370, "Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04101370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*